Drugs · acquisition-cost intelligence
ketorolac tromethamine
· ingredient ketorolacAcetic acid derivatives and related substances· KETOROLAC TROMETHAMINE 15 mg/mL; KETOROLAC TROMETHAMINE 30 mg/mL; KETOROLAC TROMETHAMINE 60 mg/2mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.76437
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 9 weeks.
2025-02-192026-05-20
Same-ingredient options by acquisition cost
Other ketorolac products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| ketorolac tromethamine | $0.15870 | −$0.60570 |
| Acular | $1.32 | +$0.55240 |
| ACULAR LS | $33.73 | +$32.96 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.